TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05668065 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01384435 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05370664 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06229665 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT05880433 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06391879 — Predictive Biomarker (PRD): VHL mRNA
Genes: VHL
Study NCT05328492 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT05517070 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04962230 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT05700292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05700292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05700292 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT05175404 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT06578039 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study NCT05694910 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04844554 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00046124 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT00046124 — Predictive Biomarker (PRD): SHBG mRNA
Genes: SHBG
Study NCT01004016 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06465264 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04893083 — Pharmacodynamic Biomarker (PDY): Leucine-rich repeat kinase 2
Genes: LRRK2; PARK8
Study NCT05028374 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05472077 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06295718 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06404203 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06404203 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study NCT06404203 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT06404203 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06126367 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study NCT04347304 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05394480 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05841199 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04668235 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02492074 — Predictive Biomarker (PRD): COMT mRNA
Genes: COMT
Study NCT06357637 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05091528 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05981638 — Safety Biomarker (SAF): Lysosomal alpha-glucosidase
Genes: GAA
Study NCT04947215 — Predictive Biomarker (PRD): LPCAT1 mRNA
Genes: LPCAT1; AYTL2; PFAAP3
Study NCT06343038 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05448404 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT05942378 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05358431 — Pharmacodynamic Biomarker (PDY): Guanine nucleotide exchange factor C9orf72
Genes: C9orf72; DENND9; DENNL72
Study NCT05092893 — Predictive Biomarker (PRD): DCD mRNA
Genes: DCD; AIDD; DSEP
Study NCT04796831 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT05531630 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05395962 — Predictive Biomarker (PRD): BLM mRNA
Genes: BLM; RECQ2; RECQL3
Study NCT00000729 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05348746 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05100823 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT05961449 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT05800054 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04722640 — Predictive Biomarker (PRD): ADAMTSL5 mRNA
Genes: ADAMTSL5; THSD6
Study NCT04817826 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT06375057 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06375057 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06375057 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT05994729 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05419102 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT04941937 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT06060574 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05750303 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05792592 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study NCT05792592 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT05126927 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06349135 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT06349135 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05364736 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05379296 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05604560 — Predictive Biomarker (PRD): CXCR1 mRNA
Genes: CXCR1; CMKAR1; IL8RA
Study NCT05770037 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT01644318 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 9
Genes: CXCL9; CMK; MIG; SCYB9
Study NCT01644318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): C-X-C motif chemokine 11
Genes: CXCL11; ITAC; SCYB11; SCYB9B
Study NCT04564625 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05229263 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT05126290 — Predictive Biomarker (PRD): CTNNA1 mRNA
Genes: CTNNA1
Study NCT05690295 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06417086 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06508606 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT06508606 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06508684 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT05685797 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study NCT06508931 — Predictive Biomarker (PRD): MB mRNA
Genes: MB
Study NCT06481956 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06481956 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05111678 — Predictive Biomarker (PRD): TSPO mRNA
Genes: TSPO; BZRP; MBR
Study NCT04825990 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04825990 — Predictive Biomarker (PRD): PARP1 mRNA
Genes: PARP1; ADPRT; PPOL
Study NCT05937048 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05007977 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study NCT05752019 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT06097884 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04550624 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT04550624 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04550624 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT04845191 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06288516 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT05278364 — Predictive Biomarker (PRD): RET mRNA
Genes: RET; CDHF12; CDHR16; PTC; RET51
Study NCT05798481 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00633230 — Predictive Biomarker (PRD): SST mRNA
Genes: SST
Study NCT05906862 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT05832736 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT06357273 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT06357273 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT05614245 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05470439 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04095689 — Safety Biomarker (SAF): Interleukin 12
Study NCT06104189 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00000765 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06334757 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06406127 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06406127 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06406127 — Safety Biomarker (SAF): BDNF
Study NCT05561972 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06481059 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study NCT05848310 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 19
Genes: FGF19; UNQ334/PRO533
Study NCT05374317 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06290856 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06345638 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06345638 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05112393 — Safety Biomarker (SAF): 51Cr-EDTA
Study NCT05994339 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05994339 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT05104437 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05104437 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06507852 — Predictive Biomarker (PRD): FH mRNA
Genes: FH
Study NCT05487443 — Predictive Biomarker (PRD): BTC mRNA
Genes: BTC
Study NCT04867213 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04836676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05689840 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04764318 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00225342 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05538351 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05217797 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05115383 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05115383 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05575648 — Predictive Biomarker (PRD): DMD mRNA
Genes: DMD
Study NCT06075992 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT06075992 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT05796115 — Monitoring Biomarker (MOI): Procalcitonin
Study NCT05020964 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05927610 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05709821 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT06531863 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06531863 — Safety Biomarker (SAF): BDNF
Study NCT05294107 — Predictive Biomarker (PRD): LGR5 mRNA
Genes: LGR5; GPR49; GPR67
Study NCT06446908 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT05475184 — Predictive Biomarker (PRD): TNKS mRNA
Genes: TNKS; PARP5A; PARPL; TIN1; TINF1; TNKS1
Study NCT05041972 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05585216 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT05092165 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04879160 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT04104659 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04890392 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05974904 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04742400 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT06151847 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study NCT06151847 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05883605 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05222009 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT05222009 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06515314 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT04886583 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05996263 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Nuclear factor erythroid 2-related factor 2
Genes: NFE2L2; NRF2
Study NCT05996263 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT05013931 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05221775 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study NCT05995977 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06518707 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study NCT06518707 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT05941507 — Predictive Biomarker (PRD): TACSTD2 mRNA
Genes: TACSTD2; GA733-1; M1S1; TROP2
Study NCT04970927 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT00001997 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT06396871 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT05414201 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04912895 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05677503 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT06197841 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT05622838 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT06265129 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06265129 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06265129 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05287048 — Predictive Biomarker (PRD): MCM5 mRNA
Genes: MCM5; CDC46
Study NCT05162053 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT04894045 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06047613 — Predictive Biomarker (PRD): S100B mRNA
Genes: S100B
Study NCT06504927 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05354375 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04708327 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05511870 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06320847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00000781 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04984655 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05052749 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05854693 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT05854693 — Safety Biomarker (SAF): BDNF
Study NCT04817241 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04816604 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04775017 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05498636 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT06351605 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT00650026 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05660928 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04963686 — Predictive Biomarker (PRD): GLS mRNA
Genes: GLS; GLS1; KIAA0838
Study NCT05352022 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05493267 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT05403554 — Predictive Biomarker (PRD): CD47 mRNA
Genes: CD47; MER6
Study NCT05403554 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study NCT05176093 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT00001041 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT05248282 — Predictive Biomarker (PRD): IGFBP3 mRNA
Genes: IGFBP3; IBP3
Study NCT05248282 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study NCT05248282 — Predictive Biomarker (PRD): VGLL3 mRNA
Genes: VGLL3
Study NCT05871190 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT05871190 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05871190 — Predictive Biomarker (PRD): Fibroblast growth factor 10
Genes: FGF10
Study NCT06358404 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT06224634 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05388149 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04998097 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04998097 — Safety Biomarker (SAF): miR-142
Genes: MIR142
Study NCT04998097 — Safety Biomarker (SAF): BDNF
Study NCT06573190 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05725733 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05441787 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Mitochondrial DNA
Study NCT05867537 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06105112 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06105112 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT06104020 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04959825 — Predictive Biomarker (PRD): MT2A mRNA
Genes: MT2A; CES1; MT2
Study NCT05113485 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05113485 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06273553 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT01321983 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT05582590 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT05253911 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05625477 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00000107 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT05539742 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT05768243 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT04877262 — Predictive Biomarker (PRD): TEF mRNA
Genes: TEF; KIAA1655
Study NCT00002389 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04800068 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04702399 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06140576 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT04924400 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05642897 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study NCT05642897 — Predictive Biomarker (PRD): FHL5 mRNA
Genes: FHL5; ACT
Study NCT06576518 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT05009329 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT00050284 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06506539 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06506539 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05478291 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05478291 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05478291 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT05705661 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05649163 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06008106 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT06008106 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT06442293 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06026995 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06026995 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT06341465 — Predictive Biomarker (PRD): ATG3 mRNA
Genes: ATG3; APG3; APG3L
Study NCT06341465 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study NCT05288205 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT04782947 — Surrogate Endpoint (SUR): Blood pressure